ALXN - Alexion Pharmaceuticals Q1 2021 Earnings Preview
Alexion Pharmaceuticals (NASDAQ:ALXN) is scheduled to announce Q1 earnings results on Friday, April 30th, before market open.The consensus EPS Estimate is $3.14 (-2.5% Y/Y) and the consensus Revenue Estimate is $1.58B (+9.7% Y/Y).Over the last 2 years, ALXN has beaten EPS estimates 100% of the time and has beaten revenue estimates 100% of the time.R&D expense estimate of $287.9M.SG&A expense estimate of $341.1M.Soliris revenue estimate of $1.05B.Over the last 3 months, EPS estimates have seen 4 upward revisions and 1 downward. Revenue estimates have seen 4 upward revisions and 2 downward.
For further details see:
Alexion Pharmaceuticals Q1 2021 Earnings Preview